How Drug Price Negotiation Is Reshaping Clinical Trial Pipelines

from A Health Podyssey · host Health Affairs

Health Affairs' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials after The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs. Order the January 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast for everyone.

Episode metadata supplied by the publisher feed · Published Feb 24, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

How Drug Price Negotiation Is Reshaping Clinical Trial Pipelines

0:00 20:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of A Health Podyssey?

This episode is 20 minutes long.

When was this A Health Podyssey episode published?

This episode was published on February 24, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this A Health Podyssey episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!